SCHEMBL16603046

SCHEMBL16603046

CN1CCC2N=CC2C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12724717 0.76 MRGPRX2 (0.36) —
SCHEMBL13313046 0.67 MRGPRX2 (0.34) —
SCHEMBL3340883 0.65 MRGPRX2 (0.33) —
SCHEMBL14932239 0.65 MRGPRX2 (0.44) —
SCHEMBL14899408 0.65 MRGPRX2 (0.30) —
SCHEMBL10154239 0.64 MRGPRX2 (0.50) —
SCHEMBL20958628 0.61 NCF1 (0.36) —
SCHEMBL20146775 0.61 NCF1 (0.36) —
SCHEMBL21271537 0.59 NCF1 (0.43) —
SCHEMBL2279449 0.59 NCF1 (0.43) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2513108-B1 NOVEL (HETEROCYCLE/CONDENSED PIPERIDINE)-(PIPERAZINYL)-1-ALCANONE OR (HETEROCYCLE/CONDENSED PYRROLIDINE)-(PIPERAZINYL)-1-ALCANONE DERIVATIVES, AND USE THEREOF AS P75 INHIBITORS SANOFI SA (FR) 2015-04-01 — — EP disclosed
Send feedback